Department of Urology, New York Presbyterian-Weill Cornell Medical College, New York, NY.
Department of Urology, New York Presbyterian-Weill Cornell Medical College, New York, NY.
Semin Radiat Oncol. 2019 Oct;29(4):333-337. doi: 10.1016/j.semradonc.2019.05.007.
The accurate determination of the frequency and severity of treatment-related complications is vital to informing patients and clinicians in their decision-making process. In published studies, complications are assed via administrative data, patient-reported outcomes, and physician-graded toxicity, each with their strengths and limitations. Administrative data provide a vast, accessible history of patient data, but are limited in the ability to accurately capture diagnosis and causality, and are subject to differing interpretations of billing codes. Patient-reported outcomes provide direct and nuanced descriptions of both symptoms and bother; but are by definition subjective, affected by nonrespondents, and results (scores) are often difficult to interpret for patients and clinicians alike. Physician-graded toxicity is a relatively more objective measure, but relies on both clinicians fully assessing all relevant symptoms and patients accurately reporting them to the clinician. Understanding these strengths and limitations will help clinicians become more informed readers of the published literature.
准确确定与治疗相关的并发症的频率和严重程度对于在决策过程中为患者和临床医生提供信息至关重要。在已发表的研究中,并发症通过管理数据、患者报告的结果和医生分级毒性进行评估,每种方法都有其优点和局限性。管理数据提供了患者数据的广泛、可访问的历史记录,但在准确捕捉诊断和因果关系方面的能力有限,并且受到计费代码不同解释的影响。患者报告的结果提供了症状和困扰的直接和细致描述;但定义上是主观的,受到无响应者的影响,并且结果(分数)对患者和临床医生来说通常难以解释。医生分级毒性是一种相对更客观的衡量标准,但依赖于临床医生全面评估所有相关症状以及患者准确向临床医生报告这些症状。了解这些优缺点将帮助临床医生成为已发表文献的更有见识的读者。